Have a feature idea you'd love to see implemented?
Let us know!
INCY Incyte Corp
Price (delayed)
$68.84
Market cap
$13.26B
P/E Ratio
404.94
Dividend/share
N/A
EPS
$0.17
Enterprise value
$11.99B
Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware. The company was founded in Palo Alto, California in 1991 and went public in 1993. Incyte has one drug,
Highlights
Incyte's revenue has increased by 13% YoY and by 6% from the previous quarter
INCY's gross profit is up by 12% year-on-year and by 5% since the previous quarter
INCY's equity is down by 36% year-on-year but it is up by 6% since the previous quarter
INCY's P/E is 175% above its last 4 quarters average of 147.2
INCY's net income has dropped by 92% year-on-year and by 67% since the previous quarter
Key stats
What are the main financial stats of INCY
Market
Valuations
Earnings
Shares outstanding
192.65M
Market cap
$13.26B
Enterprise value
$11.99B
Price to earnings (P/E)
404.94
Price to book (P/B)
4.18
Price to sales (P/S)
3.25
EV/EBIT
43.35
EV/EBITDA
32.86
EV/Sales
2.94
Revenue
$4.08B
Gross profit
$3.78B
Net income
$32.48M
EBIT
$276.53M
EBITDA
$364.8M
Free cash flow
$30.7M
Per share
Balance sheet
Liquidity
EPS
$0.17
EPS diluted
$0.14
Free cash flow per share
$0.16
Book value per share
$16.47
Revenue per share
$21.16
TBVPS
$24.59
Total assets
$5.01B
Total liabilities
$1.84B
Debt
$32.16M
Equity
$3.17B
Working capital
$1.31B
Debt to equity
0.01
Current ratio
1.87
Quick ratio
1.69
Net debt/EBITDA
-3.49
Margins
Efficiency
Dividend
EBITDA margin
9%
Gross margin
92.8%
Net margin
0.8%
Operating margin
-1.3%
Return on assets
0.6%
Return on equity
0.8%
Return on invested capital
13.3%
Return on capital employed
7.9%
Return on sales
6.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INCY stock price
How has the Incyte stock price performed over time
Intraday
2.65%
1 week
0.42%
1 month
-3.11%
1 year
13.3%
YTD
9.64%
QTD
4.15%
Financial performance
How have Incyte's revenue and profit performed over time
Revenue
$4.08B
Gross profit
$3.78B
Operating income
-$52.88M
Net income
$32.48M
Gross margin
92.8%
Net margin
0.8%
Incyte's operating income has plunged by 111% YoY
INCY's operating margin has dropped by 109% year-on-year
The net margin has dropped by 93% year-on-year and by 68% since the previous quarter
INCY's net income has dropped by 92% year-on-year and by 67% since the previous quarter
Growth
What is Incyte's growth rate over time
Valuation
What is Incyte stock price valuation
P/E
404.94
P/B
4.18
P/S
3.25
EV/EBIT
43.35
EV/EBITDA
32.86
EV/Sales
2.94
INCY's P/E is 175% above its last 4 quarters average of 147.2
INCY's EPS has shrunk by 91% YoY and by 55% QoQ
INCY's equity is down by 36% year-on-year but it is up by 6% since the previous quarter
The stock's price to book (P/B) is 23% more than its last 4 quarters average of 3.4 but 18% less than its 5-year quarterly average of 5.1
INCY's P/S is 41% below its 5-year quarterly average of 5.5 and 4.4% below its last 4 quarters average of 3.4
Incyte's revenue has increased by 13% YoY and by 6% from the previous quarter
Efficiency
How efficient is Incyte business performance
The ROE has plunged by 91% YoY and by 62% from the previous quarter
INCY's return on assets has dropped by 91% year-on-year and by 63% since the previous quarter
The ROIC has plunged by 66% YoY and by 24% from the previous quarter
INCY's ROS has shrunk by 62% YoY and by 26% QoQ
Dividends
What is INCY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INCY.
Financial health
How did Incyte financials performed over time
Incyte's total assets is 172% more than its total liabilities
The company's quick ratio has shrunk by 54% YoY
The current ratio has plunged by 52% YoY and by 2.6% from the previous quarter
The debt is 99% smaller than the equity
INCY's equity is down by 36% year-on-year but it is up by 6% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.